CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
July 2, 2025
CytoSorbents Corporation, a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, provided a regulatory update on its